StockNews.com initiated coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research report report published on Thursday. The firm issued a sell rating on the medical research company’s stock. Separately, HC Wainwright lowered OpGen from a buy rating to a neutral rating in a research note on Monday, August 14th. Check Out Our […]
Related Keywords
United States , , Dimensional Fund Advisors , Citadel Advisors , Gene Panel , Vanguard Group Inc , Virtu Financial , Opgen Inc , Free Report , Gen Trading Down , Get Free Report , Fund Advisors , Vanguard Group , Opgen Daily , Opgen , Nasdaq Opgn , Opgn , Medical , Initiated Coverage , Stocknews Com ,
comparemela.com © 2020. All Rights Reserved.